These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Noninvasive Imaging and Quantification of Radiotherapy-Induced PD-L1 Upregulation with Ehlerding EB; Lee HJ; Barnhart TE; Jiang D; Kang L; McNeel DG; Engle JW; Cai W Bioconjug Chem; 2019 May; 30(5):1434-1441. PubMed ID: 30973703 [TBL] [Abstract][Full Text] [Related]
43. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy. Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029 [TBL] [Abstract][Full Text] [Related]
44. Advancing Wuensche TE; Stergiou N; Mes I; Verlaan M; Schreurs M; Kooijman EJM; Janssen B; Windhorst AD; Jensen A; Asuni AA; Bang-Andersen B; Beaino W; Dongen GAMS; Vugts DJ Theranostics; 2022; 12(16):7067-7079. PubMed ID: 36276653 [TBL] [Abstract][Full Text] [Related]
45. Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model. Escorcia FE; Steckler JM; Abdel-Atti D; Price EW; Carlin SD; Scholz WW; Lewis JS; Houghton JL Mol Imaging Biol; 2018 Oct; 20(5):808-815. PubMed ID: 29508263 [TBL] [Abstract][Full Text] [Related]
46. Efficient PD-L1 imaging of murine glioblastoma with FUS-aided immunoPET by leveraging FcRn-antibody interaction. Chevaleyre C; Novell A; Tournier N; Dauba A; Dubois S; Kereselidze D; Selingue E; Jego B; Maillère B; Larrat B; Nozach H; Truillet C Theranostics; 2023; 13(15):5584-5596. PubMed ID: 37908736 [No Abstract] [Full Text] [Related]
47. Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule. Cai H; Shi Q; Tang Y; Chen L; Chen Y; Tao Z; Yang H; Xie F; Wu X; Liu N; Yang Y; Wu H; Tian R; Lu X; Li L Mol Pharm; 2019 May; 16(5):1950-1957. PubMed ID: 30986347 [TBL] [Abstract][Full Text] [Related]
48. DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals. Salih AK; Dominguez Garcia M; Raheem SJ; Ahiahonu WK; Price EW Inorg Chem; 2023 Dec; 62(50):20806-20819. PubMed ID: 37751491 [TBL] [Abstract][Full Text] [Related]
49. Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma. Wen X; Shi C; Zhao L; Yao L; Xu D; Lin X; Su X; Liu T; Zhuang R; Lin Q; Chen H; Guo Z; Zhang X Nucl Med Biol; 2020; 86-87():44-51. PubMed ID: 32474281 [TBL] [Abstract][Full Text] [Related]
54. Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging. Novy Z; Janousek J; Barta P; Petrik M; Hajduch M; Trejtnar F J Labelled Comp Radiopharm; 2021 Jun; 64(7):262-270. PubMed ID: 33818828 [TBL] [Abstract][Full Text] [Related]
55. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing Cho H; Al-Saden N; Lam H; Möbus J; Reilly RM; Winnik MA Nucl Med Biol; 2020; 84-85():11-19. PubMed ID: 31931305 [TBL] [Abstract][Full Text] [Related]
56. Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model. Natarajan A; Mayer AT; Reeves RE; Nagamine CM; Gambhir SS Mol Imaging Biol; 2017 Dec; 19(6):903-914. PubMed ID: 28247187 [TBL] [Abstract][Full Text] [Related]
57. Preclinical Study of a Fully Human Anti-PD-L1 Antibody as a Theranostic Agent for Cancer Immunotherapy. Xu M; Han Y; Liu G; Xu Y; Duan D; Liu H; Du F; Luo P; Liu Z Mol Pharm; 2018 Oct; 15(10):4426-4433. PubMed ID: 30133286 [TBL] [Abstract][Full Text] [Related]
59. Construction of [ Ding L; Wang F; Wang Z; Pan Y; Liu T; Cheng L; Liu W; Ding K; Zhu H; Yang Z Mol Pharm; 2024 Aug; 21(8):3992-4003. PubMed ID: 38941565 [TBL] [Abstract][Full Text] [Related]
60. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30. Perk LR; Stigter-van Walsum M; Visser GW; Kloet RW; Vosjan MJ; Leemans CR; Giaccone G; Albano R; Comoglio PM; van Dongen GA Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1857-67. PubMed ID: 18491091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]